{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:10:59Z","timestamp":1792188659092,"version":"4.4.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.cyto.2012.08.028","type":"journal-article","created":{"date-parts":[[2012,9,23]],"date-time":"2012-09-23T23:45:09Z","timestamp":1348443909000},"page":"882-889","source":"Crossref","is-referenced-by-count":50,"title":["Pretreatment circulating serum cytokines associated with follicular and diffuse large B-cell lymphoma: A clinic-based case-control study"],"prefix":"10.1016","volume":"60","author":[{"given":"Bridget","family":"Charbonneau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Ansell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L.","family":"Slager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary S.","family":"Fredericksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven C.","family":"Ziesmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Macon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Witzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian K.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne J.","family":"Novak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2012.08.028_b0005","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3322\/caac.20121","article-title":"Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.cyto.2012.08.028_b0010","doi-asserted-by":"crossref","first-page":"288","DOI":"10.6004\/jnccn.2010.0021","article-title":"NCCN clinical practice guidelines in oncology non-Hodgkin\u2019s lymphomas","volume":"8","author":"Zelenetz","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.cyto.2012.08.028_b0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1182\/blood-2005-06-2508","article-title":"Lymphoma incidence patterns by WHO subtype in the United States, 1992\u20132001","volume":"107","author":"Morton","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2012.08.028_b0020","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1002\/ajh.22099","article-title":"Follicular lymphoma: 2011 update on diagnosis and management","volume":"86","author":"Freedman","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cyto.2012.08.028_b0025","doi-asserted-by":"crossref","first-page":"6524","DOI":"10.1038\/sj.onc.1207843","article-title":"The epidemiology of non-Hodgkin\u2019s lymphoma","volume":"23","author":"Fisher","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.cyto.2012.08.028_b0030","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstrom Smedby","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2012.08.028_b0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/1055-9965.EPI-06-1056","article-title":"Infectious agents as causes of non-Hodgkin lymphoma","volume":"16","author":"Engels","year":"2007","journal-title":"Cancer Epidem Biomar Prev"},{"key":"10.1016\/j.cyto.2012.08.028_b0040","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/carcin\/bgl200","article-title":"Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin lymphoma study","volume":"28","author":"Purdue","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cyto.2012.08.028_b0045","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1158\/0008-5472.CAN-06-4752","article-title":"Immune mechanisms in non-Hodgkin lymphoma: joint effects of the TNF G308A and IL10 T3575A polymorphisms with non-Hodgkin lymphoma risk factors","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.cyto.2012.08.028_b0050","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1182\/blood-2007-05-088682","article-title":"Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma","volume":"110","author":"Cerhan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2012.08.028_b0055","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2141.2006.06141.x","article-title":"Polymorphisms in innate immunity genes and risk of non-Hodgkin lymphoma","volume":"134","author":"Forrest","year":"2006","journal-title":"Brit J Haematol"},{"key":"10.1016\/j.cyto.2012.08.028_b0060","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/sj.gene.6364337","article-title":"Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk","volume":"7","author":"Nieters","year":"2006","journal-title":"Genes Immun"},{"key":"10.1016\/j.cyto.2012.08.028_b0065","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1521-6616(03)00214-6","article-title":"Non-Hodgkin\u2019s B cell lymphoma in persons with acquired immunodeficiency syndrome is associated with increased serum levels of IL10, or the IL10 promoter-592 C\/C genotype","volume":"109","author":"Breen","year":"2003","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cyto.2012.08.028_b0070","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1055-9965.EPI-11-0037","article-title":"B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma","volume":"20","author":"Breen","year":"2011","journal-title":"Cancer Epidem Biomark Prev"},{"key":"10.1016\/j.cyto.2012.08.028_b0075","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1006\/clim.1999.4760","article-title":"The development of AIDS-associated Burkitt\u2019s\/small noncleaved cell lymphoma is preceded by elevated serum levels of interleukin 6","volume":"92","author":"Breen","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.cyto.2012.08.028_b0080","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/s10552-010-9560-3","article-title":"Circulating cytokines and risk of B-cell non-Hodgkin lymphoma: a prospective study","volume":"21","author":"Gu","year":"2010","journal-title":"Cancer Cause Control"},{"key":"10.1016\/j.cyto.2012.08.028_b0085","doi-asserted-by":"crossref","first-page":"4898","DOI":"10.1158\/0008-5472.CAN-11-0165","article-title":"Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma","volume":"71","author":"Purdue","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.cyto.2012.08.028_b0090","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1158\/1055-9965.EPI-09-1237","article-title":"Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European prospective investigation into cancer and nutrition","volume":"19","author":"Saberi Hosnijeh","year":"2010","journal-title":"Cancer Epidem Biomark Prev"},{"key":"10.1016\/j.cyto.2012.08.028_b0095","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/ajh.22119","article-title":"Circulating cytokine levels Epstein-Barr viremia and risk of acquired immunodeficiency syndrome-related non-Hodgkin lymphoma","volume":"86","author":"Rabkin","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cyto.2012.08.028_b0100","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.23259","article-title":"Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients","author":"Ansell","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cyto.2012.08.028_b0105","first-page":"95","article-title":"Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma","volume":"2","author":"Cerhan","year":"2011","journal-title":"Int J Mol Epidem Genet"},{"key":"10.1016\/j.cyto.2012.08.028_b0110","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1200\/JCO.2010.28.6674","article-title":"Vitamin D insufficiency and prognosis in non-Hodgkin\u2019s lymphoma","volume":"28","author":"Drake","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.cyto.2012.08.028_b0115","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2559.2010.03706.x","article-title":"The challenge of the microenvironment in B-cell lymphomas","volume":"58","author":"Coupland","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.cyto.2012.08.028_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13547500701674063","article-title":"Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review","volume":"13","author":"Bien","year":"2008","journal-title":"Biomarkers"},{"key":"10.1016\/j.cyto.2012.08.028_b0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1155\/MI.2005.121","article-title":"On the role of sIL-2R measurements in rheumatoid arthritis and cancers","volume":"2005","author":"Witkowska","year":"2005","journal-title":"Mediat Inflamm"},{"key":"10.1016\/j.cyto.2012.08.028_b0130","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2165\/00003495-199346030-00009","article-title":"Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer","volume":"46","author":"Whittington","year":"1993","journal-title":"Drugs"},{"key":"10.1016\/j.cyto.2012.08.028_b0135","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3343\/kjlm.2010.30.6.600","article-title":"Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Ralpha) in patients with non-Hodgkin\u2019s lymphoma","volume":"30","author":"Jo","year":"2010","journal-title":"Korean J Lab Med"},{"key":"10.1016\/j.cyto.2012.08.028_b0140","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1349-7006.2009.01167.x","article-title":"Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma","volume":"100","author":"Morito","year":"2009","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cyto.2012.08.028_b0145","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1182\/blood-2011-03-340885","article-title":"Soluble IL-2Ralpha facilitates IL-2-mediated immune responses and predicts reduced survival in follicular B-cell non-Hodgkin lymphoma","volume":"118","author":"Yang","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.cyto.2012.08.028_b0150","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4049\/jimmunol.139.5.1541","article-title":"A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha","volume":"139","author":"Seckinger","year":"1987","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.08.028_b0155","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/343336a0","article-title":"Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor","volume":"343","author":"Hannum","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.cyto.2012.08.028_b0160","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI20742","article-title":"TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist\u2013deficient mice","volume":"114","author":"Horai","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2012.08.028_b0165","article-title":"Serum cytokines in follicular lymphoma correlation of TGF-beta and VEGF with survival","author":"Labidi","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cyto.2012.08.028_b0170","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S1359-6101(03)00043-1","article-title":"The biology of IL-12: coordinating innate and adaptive immune responses","volume":"14","author":"Watford","year":"2003","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.cyto.2012.08.028_b0175","doi-asserted-by":"crossref","first-page":"5432","DOI":"10.1158\/1078-0432.CCR-04-0540","article-title":"Phase II clinical trial of interleukin-12 in patients with relapsed and refractory non-Hodgkin\u2019s lymphoma and Hodgkin\u2019s disease","volume":"10","author":"Younes","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cyto.2012.08.028_b0180","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1172\/JCI59806","article-title":"IL-12 upregulates TIM-3 expression and induces T cell exhaustion in patients with follicular B cell non-Hodgkin lymphoma","volume":"122","author":"Yang","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cyto.2012.08.028_b0185","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.cyto.2012.08.028_b0190","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.182.5.1301","article-title":"Human Mig chemokine: biochemical and functional characterization","volume":"182","author":"Liao","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.cyto.2012.08.028_b0195","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","article-title":"IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis","volume":"170","author":"Li","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.08.028_b0200","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1751-553X.2007.00951.x","article-title":"Correlation of serum IL-6, IL-8 and IL-10 levels with clinicopathological features and prognosis in patients with diffuse large B-cell lymphoma","volume":"30","author":"Nacinovic-Duletic","year":"2008","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/j.cyto.2012.08.028_b0205","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking","volume":"168","author":"Dufour","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.08.028_b0210","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4049\/jimmunol.171.3.1401","article-title":"Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10-\/- mice","volume":"171","author":"Singh","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.08.028_b0215","doi-asserted-by":"crossref","first-page":"927","DOI":"10.4049\/jimmunol.161.2.927","article-title":"The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor","volume":"161","author":"Tannenbaum","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.08.028_b0220","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4049\/jimmunol.156.2.693","article-title":"Cytokine and chemokine expression in tumors of mice receiving systemic therapy with IL-12","volume":"156","author":"Tannenbaum","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.cyto.2012.08.028_b0225","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1172\/JCI113809","article-title":"Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs","volume":"82","author":"Miedema","year":"1988","journal-title":"J Clin Invest"}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612006692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466612006692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,25]],"date-time":"2023-06-25T22:42:46Z","timestamp":1687732966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466612006692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1043466612006692"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2012.08.028","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}